Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

समान संसाधन

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  द्वारा: Caorsi, R, और अन्य
  प्रकाशित: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  द्वारा: Caorsi, Roberta, और अन्य
  प्रकाशित: (2013)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  द्वारा: Bibalo, C, और अन्य
  प्रकाशित: (2011)
• Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
  द्वारा: Toker, Ori, और अन्य
  प्रकाशित: (2010)
• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  द्वारा: Svetlana Olegovna Salugina, और अन्य
  प्रकाशित: (2014-12-01)